In Vitro Fertilization-Embryo Transfer (IVF-ET)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Female, aged >= 20 and < 40 years; (2)Preparing for IVF, ICSI or PGD; (3)Voluntarily signed the informed consent.
Exclusion criteria
Exclusion criteria: (1)Donor embryo transfer; (2)Chronic diseases associated with adverse pregnancy outcomes, such as hypertension, clinically symptomatic heart disease, diabetes, liver disease, kidney disease, severe anemia, history of venous thrombosis, history of pulmonary embolism or cerebrovascular events, and malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Endometrial thickness;Serum level of AMH;Embryo implantation rate;Antral follicle count;Basal serum level of LH;Early pregnancy loss rate;Uterine artery blood flow resistance index (RI);Endometrial and?subendometrial vascularization flow index (VFI);Endometrial and?subendometrial flow index (FI);Menstrual volume;Number of eggs harvested;Endometrial volume;Continuous pregnancy rate;Available embryo rate;Fertilization rate;Endometrial and?subendometrial vascularization index (VI);Live birth rate;High-quality embryo rate;Endometrial morphology;Basal serum level of E2;Basal serum level of FSH;Menstrual duration;SAS score;Cycle cancellation rate;Uterine artery blood flow pulsation index (PI);Cleavage rate;Biochemical pregnancy rate;Menstrual cycle; | — |
Countries
China